Analysis of a panel of human cancer cell lines revealed high CHD9 protein levels in SNB19 glioblastoma and K562 chronic myelogenous leukemia cell lines (Fig 5A and 5B, S8 Fig). This evidence concerns the gene CHD9 and chronic myelogenous leukemia, BCR-ABL1 positive.